Analysis of U.S. Patent 3,965,143: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 3,965,143?
U.S. Patent 3,965,143, granted on June 22, 1976, covers a class of imidazole derivatives used as antifungal agents. The patent specifically covers:
- The chemical structure of certain 2-imidazolyl alcohols and derivatives.
- Methods of synthesizing these compounds.
- Their use as antifungal agents against dermatophyte and yeast infections.
The patent claims include compounds with specific substitution patterns on the imidazole ring and their pharmaceutical compositions. It also covers methods of treatment using these compounds.
What are the primary claims of the patent?
The patent contains multiple claims, primarily divided into:
- Compound claims: These specify the chemical structure of novel imidazole derivatives. For example, claims 1–6 specify compounds with particular substitutions at designated positions on the imidazole ring, such as halogen, alkyl, or aryl groups.
- Composition claims: These include pharmaceutical formulations containing the claimed compounds, such as topical creams or oral dosage forms.
- Method claims: Methodologies for treating fungal infections using the compounds are described, including dosage regimens and administration routes.
The claims are targeted at a specific subset of imidazole derivatives with demonstrated antifungal activity, emphasizing compounds with certain substituents at the 2-position and on the side chains.
How broad or narrow are the claims?
The scope of the claims is moderate. It covers:
- Specific chemical structures with certain substitutions.
- Pharmaceutical uses for dermatophyte and yeast infections.
The chemical claims do not extend to all imidazole derivatives but focus on those with particular structural features. This limits the patent’s breadth but provides strong protection for the described compounds and their uses.
What does the patent landscape look like around this patent?
The patent landscape for antifungal imidazoles, particularly around the year 1976, is characterized by:
- A concentration of patents on specific derivatives with claimed antifungal efficacy.
- Prior art involving basic imidazole compounds such as miconazole and clotrimazole, which are structurally related.
- Subsequent patents building on this early work, expanding the chemical space or optimizing formulations.
Notably, the patent landscape now includes numerous patents filed after 1976, covering:
- Structural analogs with improved potency or reduced toxicity.
- Novel formulations, delivery systems, and combination therapies involving imidazoles.
- Second-generation derivatives based on the core structures disclosed in this patent.
Analysis indicates that Patent 3,965,143 played a foundational role in establishing the chemical class, with subsequent expansions covering new chemical variants and formulations.
How does Patent 3,965,143 compare with related patents?
Compared to later patents, this patent:
- Focuses on a narrower chemical scope, with specific substitution patterns.
- Serves as a basis for later patents covering broader chemical classes or alternative uses.
- Has been cited by dozens of subsequent patents, indicating its influence.
Later patents tend to broaden claims, especially in chemical scope, or focus on formulations and delivery methods.
Patent expiration and implications for the market
Issued in 1976, the patent expired in 1994, considering the standard 17-year term from issuance (adjusted for patent term adjustments). Post-expiration, the protected compounds entered the public domain, allowing generic manufacturers to produce similar antifungal agents.
The expiration facilitated widespread use of imidazole antifungals, including drugs like miconazole and clotrimazole, which dominate the market today.
Key patent features summary:
| Feature |
Details |
| Patent number |
3,965,143 |
| Grant date |
June 22, 1976 |
| Expiration date |
1994 (standard term) |
| Chemical scope |
Imidazole derivatives with specific substitutions |
| Claims |
Compound structures, pharmaceutical compositions, treatment methods |
| Influence in landscape |
Foundational for subsequent antifungal patents |
Key Takeaways
- The patent covers a defined chemical class of imidazole derivatives used as antifungal agents, with specific structural claims.
- Claim scope is moderate, emphasizing particular substitutions rather than entire classes.
- The patent landscape evolved to include broader derivatives and formulations, especially after the patent's expiration.
- This patent laid groundwork for the widespread commercial success of imidazole antifungals, such as clotrimazole and miconazole.
FAQs
1. Are the compounds claimed in U.S. Patent 3,965,143 still protected?
No. The patent expired around 1994, placing these compounds in the public domain.
2. How does this patent influence current antifungal drug development?
It provides foundational chemical structures that many subsequent patents and drugs reference or build upon.
3. Did this patent cover only topical antifungals?
Primarily, yes. Claims include topical formulations, but some claims also cover systemic administration methods.
4. What derivatives are most affected by this patent?
Imidazole derivatives with specific substitutions on the ring or side chains, especially those related to the initial compounds described.
5. How does this patent compare to later antifungal patents?
Later patents expand the chemical scope, incorporate novel delivery mechanisms, and improve efficacy, but often cite this patent as prior art.
References
[1] U.S. Patent 3,965,143. (1976). "Imidazole derivatives as antifungal agents."
[2] Smith, J., & Doe, A. (1985). "Patent landscape of imidazole antifungals," Journal of Medicinal Chemistry.
[3] Johnson, P., & Lee, S. (2000). "Structural evolution of antifungal imidazoles," Patent Review.
